US2005272773A1PendingUtilityA1
Use of R (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-flurophenyl)-ethyl]-4- piperidinemethanol for the treatment of sleep disorders and process for making pharmaceutical composition
Est. expiryAug 28, 2018(expired)· nominal 20-yr term from priority
A61K 31/445A61P 25/20
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for making a pharmaceutical composition for treating a variety of sleep disorders comprising an effective amount of R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof is disclosed and claimed.
Claims
exact text as granted — not AI-modified1 . A method of manufacturing a pharmaceutical composition for the treatment of sleep disorders containing R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof, comprising mixing R-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof with a pharmaceutically acceptable carrier.
Join the waitlist — get patent alerts
Track US2005272773A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.